DrugPatentWatch Database Preview
Drugs in Development Information for Butylphthalide
Email this page to a colleague
See Plans and PricingWhat is the development status for investigational drug Butylphthalide?
Butylphthalide is an investigational drug.
There have been 14 clinical trials for Butylphthalide.
The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2015.
The most common disease conditions in clinical trials are Stroke, Cerebral Infarction, and Ischemia. The leading clinical trial sponsors are CSPC-NBP Pharmaceutical Co., Ltd., The Second Hospital of Hebei Medical University, and Peking Union Medical College Hospital.
Summary for Butylphthalide
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 160 |
| WIPO Patent Applications | 73 |
| Japanese Patent Applications | 3 |
| Clinical Trial Progress | Phase 3 (2015-07-01) |
| Vendors | 54 |
Recent Clinical Trials for Butylphthalide
| Title | Sponsor | Phase |
|---|---|---|
| NBP in Patients With Moyamoya Disease of High Risk for Ischemic Cerebrovascular Events | Peking University International Hospital | Phase 3 |
| NBP in Patients With Moyamoya Disease of High Risk for Ischemic Cerebrovascular Events | yuanli Zhao | Phase 3 |
| Study of Collateral Circulation in Patients With Symptomatic Intracranial Anterior Circulation Occlusion | The Second Hospital of Hebei Medical University | Phase 4 |
Clinical Trial Summary for Butylphthalide
Top disease conditions for Butylphthalide
Top clinical trial sponsors for Butylphthalide
US Patents for Butylphthalide
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
